Gene · 2119
Papers1,680
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,680
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Transcriptional and epigenetic reprogramming, lineage plasticity and therapy resistance in prostate cancer. | J Natl Cancer Cent | 2026 | 41738031 | PubTator, text mining | PubMed |
| Fitness Training for γδ T cells in mouse and human atherosclerosis takes place in plaques and artery tertiary lymphoid organs. | Genome Med | 2026 | 41736145 | PubTator, text mining | PubMed |
| Cancer neuroscience: signaling pathways and new therapeutic strategies for cancer. | Signal Transduct Target Ther | 2026 | 41724757 | PubTator, text mining | PubMed |
| Serum Amyloid A (SAA) induces transcription affecting inflammation. | PLoS One | 2026 | 41712650 | PubTator, text mining | PubMed |
| Comprehensive tumour-immune profiling reveals TREM2+ tumour-associated macrophages facilitating lymph node metastasis in head and neck squamous cell carcinoma. | Clin Transl Med | 2026 | 41612852 | PubTator, text mining | PubMed |
| Role of the ETV5/p38 Signaling Axis in Aggressive Thyroid Cancer Cells. | Mol Cancer Ther | 2026 | 41544239 | PubTator, text mining | PubMed |
| Mixed-model and transcriptome-wide association analyses identify transcription factors and genes associated with colorectal cancer susceptibility. | Nat Commun | 2026 | 41540004 | PubTator, text mining | PubMed |
| ETS Translocation Variant 5 Negatively Modulates Innate Immunity to Facilitate Epstein-Barr Virus Reactivation. | J Med Virol | 2026 | 41459768 | PubTator, text mining | PubMed |
| ETV5 upregulates PD-L1 transcription to inhibit cytotoxic CD8+ T cell proliferation in colorectal cancer. | Sci China Life Sci | 2026 | 41203951 | PubTator, text mining | PubMed |
| PRC2/FOXO1-Mediated Repression Determines Interchangeability of ETS Oncogenes in Prostate Cancer and Ewing Sarcoma. | Mol Cancer Res | 2026 | 40971246 | PubTator, text mining | PubMed |
| ETV4-Mediated PD-L1 Upregulation Promotes Immune Evasion and Predicts Poor Immunotherapy Response in Melanoma. | Oncol Res | 2025 | 41502516 | PubTator, text mining | PubMed |
| Systematic Characterization of LUHMES Cell-Based Parkinson's Disease Models Reveals Potential Novel Drug Targets. | Mol Neurobiol | 2025 | 41405732 | PubTator, text mining | PubMed |
| Species-specific chromatin architecture and neurogenesis mediated by a human enhancer. | bioRxiv | 2025 | 41357990 | PubTator, text mining | PubMed |
| Monocyte-driven IFN and TNF programs orchestrate inflammatory networks in antisynthetase syndrome-associated interstitial lung disease. | Front Immunol | 2025 | 41209011 | PubTator, text mining | PubMed |
| ETV5 transcriptionally activates LGR4 and promotes cancer cell invasion and migration of nasopharyngeal carcinoma. | J Mol Histol | 2025 | 41152659 | PubTator, text mining | PubMed |
| The m6A modification in cancer: roles, implications, and its potential in therapy. | Mol Biomed | 2025 | 40986143 | PubTator, text mining | PubMed |
| A double-negative prostate cancer subtype is vulnerable to SWI/SNF-targeting degrader molecules. | bioRxiv | 2025 | 40949972 | PubTator, text mining | PubMed |
| Regulatory mechanisms of Th9 cell differentiation. | Front Immunol | 2025 | 40948790 | PubTator, text mining | PubMed |
| SHLP2 alleviates allergic asthma by inhibiting ETV5/GSDMD signaling pathway-mediated pyroptosis. | Cell Signal | 2025 | 40935298 | PubTator, text mining | PubMed |
| Pinpointing novel targets for osteoarthritis: A comprehensive cross-omics integration analysis. | Medicine (Baltimore) | 2025 | 40859561 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2119/papers?page=2